A Review of Antithrombotic Options and Strategies for STEMI

Complimentary Accredited Breakfast Symposium

February 26, 2010

6:30 am – 8:00 am

Loews Miami Beach Hotel
1601 Collins Avenue
Miami Beach, Florida 33139
Room: Cowrie 1 & 2

There is no registration fee for participating in this program.


Faculty:

Sameer Mehta, MD, FACC, MBA
Voluntary Associate Professor of Medicine
University of Miami Miller School of Medicine
President Indo American Society of Interventional Cardiology
Miami, Florida

Roxana Mehran, MD, FACC
Associate Professor of Medicine
Joint Chief Scientific Offices, Clinical Trial Center
Columbia University
Director of Outcomes Research
Data Coordination & Analysis for the Center for Interventional Vascular Therapies
Cardiovascular Research Foundation
Director of Data Coordinating & Analysis Center
New York, New York

Samin Sharma, MD, FACC
Director, Cardiac Catheterization Laboratory & Intervention
Zena & Michael A. Weiner Professor of Medicine
The Mount Sinai Medical Center
Division of Cardiology
New York, New York

Dean Kereiakes, MD
Medical Director
The Christ Hospital Heart and Vascular Center/The Linder Center
Professor of Medicine
Ohio State University
Cincinnati, Ohio

Agenda

6:30AM-7:00AM
Registration/Breakfast

7:00AM-7:05AM
Welcome and Introduction
Sameer Mehta, MD, FACC, MBA

7:05AM-7:20AM
Antithrombotic agents in patients within STEMI undergoing emergency PCI.
Roxana Mehran, MD, FACC

7:20AM-7:35AM
Reviewing the Latest Platelet Inhibition and Patient Outcomes STEMI Data:
Dean Kereiakes, MD

7:35AM-7:50AM
Applying Study Results into the Urgent Clinical Setting of STEMI Management
Samin Sharma, MD, FACC

7:50AM-8:00AM
Question and Answer/Conclusion

Learning Objectives
After completing this activity, participants should be able to:

• Discuss the role of emerging antithrombotic therapy in patients with STEMI undergoing emergency PCI
• Review limitations and potential adverse clinical events with current antithrombotic therapy in STEMI patients
• Review and apply the latest study results in determining the best available options of antithrombotic therapy within the urgent clinical setting

Target Audience
This activity is designed for Interventional Cardiologists, General Cardiologists, Emergency Room Physicians, Cardiovascular Nurses and Medical Directors

Activity Overview
This symposium will occur in Cowrie 1 & 2 of the Loews Miami Beach Hotel on Friday, February, 26 from 6:30 am to 8:00 am. Registration and breakfast will occur from 6:30 am – 7:00 am, the educational activity from 7:00 am – 8:00 am. A question-and-answer session will follow each presentation.

For questions regarding this educational activity, please contact Trish Levy at 609-630-6242

Accreditation:

CME:

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 1 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

AHRA:
Credit Pending.

Sponsored by North American Center for Continuing Medical Education, LLC


Supported by an educational grant from AstraZeneca

To register for this symposium, go to
http://www.regonline.com/antithrombotic

There is no registration fee for attending this program.